📋 Tender Overview
PROJECT ID
110591
TOTAL FUNDING
CAD 50,500.00
IDRC OFFICER
Samuel Oji Oti
PROJECT STATUS
Active
DURATION
6 months
Description: Vaccines remain one of the most cost-effective public health interventions for preventing and controlling infectious disease outbreaks and ensuring global health security. Yet Africa produces less than 1% of the vaccines used across the continent. To bridge this gap, the African Union has set an ambitious target of supporting the African vaccine manufacturing industry to develop, produce and supply over 60% of the total vaccine doses required by the continent by 2040. Promising progress is already underway toward achieving this vision. For example, in December 2023, Rwanda launched Africa's first-ever mRNA vaccine manufacturing facility.
However, efforts to boost Africa's vaccine production capacity are largely focused on strengthening manufacturing and distribution with minimal emphasis on improving vaccine uptake. Vaccine uptake remains a huge global challenge. Social and behavioural science research can facilitate the development of targeted interventions to overcome vaccination barriers, build public trust in vaccines and strengthen community engagement, ultimately fostering more effective and equitable vaccination programs across Africa.
This project will support development of a detailed proposal for a capacity-strengthening program focused on social and behavioural research for vaccine uptake in Africa. The proposal will be developed through stakeholder mapping, scoping reviews, expert consultations and a series of writing workshops.
